Monitoring of a multi-modal schedule for the treatment of disseminated breast cancer.
39 women and 1 man have been monitored by sequential CEA, immunoglobulin, lymphocyte and monocyte readings, hydroxyproline excretion, scans and x-rays. CEA is shown to be a useful monitor of disease. The significance of the lymphocyte counts is discussed.
D001943:Breast Neoplasms / Q000097:blood / Q000276:immunology / Q000628:therapy*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002986:Clinical Trials as Topic; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007167:Immunotherapy / Q000379:methods; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D011425:Propionibacterium acnes; D012882:Skin Tests
D002272:Carcinoembryonic Antigen; D006454:Hemoglobins; D007136:Immunoglobulins